Wednesday, October 9, 2013

Amaranth Medical Gets $20M

Mountain View-based Amaranth Medical, which is developing bioresorbable, coronary scaffolds use for treating coronary artery disease, said this week it has raised $20M in a Series B funding. The funding came from DCP Management of Singapore, as well as Bio*One Capital, Charter Life Sciences, Phillip Capital, and Venstar Capital. The firm said the funds will go towards continued development of its first product. More information »